Jessica Michie, PhD
About Jessica Michie, PhD
Jessica Michie, PhD, is the Associate Medical Lead for Haematology Early Assets at Bristol Myers Squibb in Melbourne, Australia.
Company
Jessica Michie currently works at Bristol Myers Squibb. She serves as the Associate Medical Lead for Haematology - Early Assets in Melbourne, Victoria, Australia.
Title
Jessica Michie holds the position of Associate Medical Lead, Haematology - Early Assets at Bristol Myers Squibb. In this role, she is involved in overseeing early-stage hematology assets.
Professional Background
Jessica Michie has accumulated diverse experience in medical and scientific roles. From 2020 to 2021, she worked as a Medical Science Liaison at Bristol Myers Squibb in Melbourne, Victoria, Australia. Before that, she spent three years at the Peter MacCallum Cancer Centre as a PhD Student, focusing on cancer immunology. Prior to her PhD, she was a Research Associate (Intern) at Novartis Institutes for BioMedical Research in San Francisco, CA from 2014 to 2015.
Educational Background
Jessica Michie has a robust educational background in medical sciences. She earned a Doctor of Philosophy (PhD) in Medicine, Dentistry and Health Sciences from the University of Melbourne from 2017 to 2020. She also holds a Bachelor of Science (BSc) in Pharmacology with Industrial Placement from the University of Leeds, completed from 2012 to 2016. Additionally, she completed the Medicines Australia Continuing Education Program with Distinction at the University of Tasmania from 2020 to 2021.
Research and Contributions
Jessica Michie has made significant research contributions, particularly in cancer immunology. Her post-graduate research at the Peter MacCallum Cancer Centre focused on enhancing CAR T cell therapy under the supervision of Dr. Paul Beavis and Associate Professor Jane Oliaro. She authored a PhD thesis titled 'Enhancing CAR T cell Therapy' which highlights her contributions to strengthening cancer treatment methodologies.
Academic Achievements
Jessica Michie has been recognized for her academic excellence throughout her studies. She was awarded the Bowmer Prize for Pharmacology for achieving the highest final year percentage in BSc Pharmacology at the University of Leeds and received a Dean’s List citation during her undergraduate studies. Her academic record reflects her dedication and expertise in the field of pharmacology.